ADAR RNA Modifications, the Epitranscriptome and Innate Immunity
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR1 is primarily responsible for editing dsRNA duplexes formed by repetitive elements, and its deletion or inactivation triggers an innate immune response [4].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [4]
In the citing paper
“When this dsRNA is unedited, it can activate cytoplasmic dsRNA sensors, which recognize these structures as “non-self” RNA (for review [4]).”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [4]
In the citing paper
“Such cooperation may help limit the accumulation of immunogenic endogenous dsRNA, as both ADAR editing and RNA exosome-mediated decay prevent inappropriate activation of immune response [4, 89, 95, 96].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [4]
In the citing paper
“In this model, ADAR proteins, in addition to editing, act as sensors of specific structured RNA and facilitate recruitment of the exosome to limit their accumulation and the activation of the innate immune response (for review [4]).”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationMicroRNAs as regulatory elements in immune system logic
Mehta, A., & Baltimore, D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.40 · Cited by 704
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature · doi:10.1038/s41586-018-0768-9 · Cited by 697
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Han, L., Diao, L., Yu, S., Xu, X., Li, J., Zhang, R., Yang, Y., Werner, H. M. J., Eterovic, A. K., Yuan, Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.013 · Cited by 542
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
Chung, H., Calis, J. J. A., Wu, X., Sun, T., Yu, Y., Sarbanes, S. L., Dao Thi, V. L., Shilvock, A. R., Hoffmann, H.-H., Rosenberg, B. R., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.038 · Cited by 538
Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation
Ahmad, S., Mu, X., Yang, F., Greenwald, E., Park, J. W., Jacob, E., Zhang, C.-Z., & Hur, S. (2018) · Cell · doi:10.1016/j.cell.2017.12.016 · Cited by 449
Rodero, M. P., & Crow, Y. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20161596 · Cited by 433
Research works printed but not linked: 86
- Boccaletto, 2018, MODOMICS: a database of RNA modification pathways. 2017 update, Nucleic Acids Res., 46, D303, 10.1093/nar/gkx1030 · DOI · Paper page
- Saletore, 2012, The birth of the epitranscriptome: deciphering the function of RNA modifications, Genome Biol., 13, 175, 10.1186/gb-2012-13-10-175 · DOI · Paper page
- Mannion, 2014, The RNA-editing enzyme ADAR1 controls innate immune responses to RNA, Cell Rep., 9, 1482, 10.1016/j.celrep.2014.10.041 · DOI · Paper page
- O’Connell, 2015, The epitranscriptome and innate immunity, PLoS Genet., 11, 10.1371/journal.pgen.1005687 · DOI
- Eisenberg, 2018, A-to-I RNA editing – immune protector and transcriptome diversifier, Nat. Rev. Genet., 19, 473, 10.1038/s41576-018-0006-1 · DOI · Paper page
- Mannion, 2015, New insights into the biological role of mammalian ADARs; the RNA editing proteins, Biomolecules, 5, 2338, 10.3390/biom5042338 · DOI
- Matthews, 2016, Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity, Nat. Struct. Mol. Biol., 23, 426, 10.1038/nsmb.3203 · DOI · Paper page
- Patterson, 1995, Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase, Mol. Cell. Biol., 15, 5376, 10.1128/MCB.15.10.5376 · DOI · Paper page
- Desterro, 2003, Dynamic association of RNA-editing enzymes with the nucleolus, J. Cell Sci., 116, 1805, 10.1242/jcs.00371 · DOI · Paper page
- Bazak, 2014, A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes, Genome Res., 24, 365, 10.1101/gr.164749.113 · DOI · Paper page
- Licht, 2019, Inosine induces context-dependent recoding and translational stalling, Nucleic Acids Res., 47, 3, 10.1093/nar/gky1163 · DOI · Paper page
- Tan, 2017, Dynamic landscape and regulation of RNA editing in mammals, Nature, 550, 249, 10.1038/nature24041 · DOI · Paper page
- Serra, 2004, Pronounced instability of tandem IU base pairs in RNA, Nucleic Acids Res., 32, 1824, 10.1093/nar/gkh501 · DOI
- Liddicoat, 2015, RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself, Science, 349, 1115, 10.1126/science.aac7049 · DOI · Paper page
- Pestal, 2015, Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development, Immunity, 43, 933, 10.1016/j.immuni.2015.11.001 · DOI · Paper page
- Roost, 2015, Structure and thermodynamics of N6-methyladenosine in RNA: a spring-loaded base modification, J. Am. Chem. Soc., 137, 2107, 10.1021/ja513080v · DOI · Paper page
- Heale, 2009, Editing independent effects of ADARs on the miRNA/siRNA pathways, EMBO J., 28, 3145, 10.1038/emboj.2009.244 · DOI · Paper page
- Ota, 2013, ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing, Cell, 153, 575, 10.1016/j.cell.2013.03.024 · DOI · Paper page
- Ohman, 2000, In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site, RNA, 6, 687, 10.1017/S1355838200000200 · DOI
- Kallman, 2003, ADAR2 A→I editing: site selectivity and editing efficiency are separate events, Nucleic Acids Res., 31, 4874, 10.1093/nar/gkg681 · DOI
- Ablasser, 2020, Regulation of cGAS- and RLR-mediated immunity to nucleic acids, Nat. Immunol., 21, 17, 10.1038/s41590-019-0556-1 · DOI · Paper page
- Wu, 2013, Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5, Cell, 152, 276, 10.1016/j.cell.2012.11.048 · DOI · Paper page
- Hartner, 2004, Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1, J. Biol. Chem., 279, 4894, 10.1074/jbc.M311347200 · DOI · Paper page
- Wang, 2015, ADAR1 prevents liver injury from inflammation and suppresses interferon production in hepatocytes, Am. J. Pathol., 185, 3224, 10.1016/j.ajpath.2015.08.002 · DOI
- Rawling, 2014, Parts, assembly and operation of the RIG-I family of motors, Curr. Opin. Struct. Biol., 25, 25, 10.1016/j.sbi.2013.11.011 · DOI
- Louber, 2015, Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5, BMC Biol., 13, 54, 10.1186/s12915-015-0166-9 · DOI
- Luo, 2011, Structural insights into RNA recognition by RIG-I, Cell, 147, 409, 10.1016/j.cell.2011.09.023 · DOI · Paper page
- Di Giorgio, 2020, Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2, Sci. Adv., 6, 10.1126/sciadv.abb5813 · DOI · Paper page
- Samuel, 2012, ADARs: viruses and innate immunity, Curr. Top. Microbiol. Immunol., 353, 163
- Yanai, 2020, ADAR2 is involved in self and nonself recognition of Borna disease virus genomic RNA in the nucleus, J. Virol., 94, e01513, 10.1128/JVI.01513-19 · DOI
- Li, 2016, Ubiquitin-dependent turnover of adenosine deaminase acting on RNA 1 (ADAR1) is required for efficient antiviral activity of type I Interferon, J. Biol. Chem., 291, 24974, 10.1074/jbc.M116.737098 · DOI
- Roth, 2019, Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity, Nat. Methods, 16, 1131, 10.1038/s41592-019-0610-9 · DOI · Paper page
- Bou-Nader, 2019, The search for a PKR code-differential regulation of protein kinase R activity by diverse RNA and protein regulators, RNA, 25, 539, 10.1261/rna.070169.118 · DOI
- Li, 2017, Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line, eLife, 6, 10.7554/eLife.25687 · DOI · Paper page
- Blango, 2016, Identification of the long, edited dsRNAome of LPS-stimulated immune cells, Genome Res., 26, 852, 10.1101/gr.203992.116 · DOI
- Li, 2018, ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization, FASEB J., 32, 5162, 10.1096/fj.201701449R · DOI
- Solomon, 2017, RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure, Nat. Commun., 8, 1440, 10.1038/s41467-017-01458-8 · DOI
- Porath, 2017, Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance, Genome Biol., 18, 185, 10.1186/s13059-017-1315-y · DOI · Paper page
- Keegan, 2011, Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects, Nucleic Acids Res., 39, 7249, 10.1093/nar/gkr423 · DOI
- Khan, 2020, Membrane and synaptic defects leading to neurodegeneration in Adar mutant Drosophila are rescued by increased autophagy, BMC Biol., 18, 15, 10.1186/s12915-020-0747-0 · DOI
- Palladino, 2000, A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity, Cell, 102, 437, 10.1016/S0092-8674(00)00049-0 · DOI · Paper page
- Deddouche, 2008, The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in Drosophila, Nat. Immunol., 9, 1425, 10.1038/ni.1664 · DOI · Paper page
- Deng, 2020, Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila, Nat. Commun., 11, 1580, 10.1038/s41467-020-15435-1 · DOI
- Paradkar, 2014, Dicer-2-dependent activation of Culex Vago occurs via the TRAF-Rel2 signaling pathway, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0002823 · DOI
- Scadden, 2001, RNAi is antagonized by A→I hyper-editing, EMBO Rep., 2, 1107, 10.1093/embo-reports/kve244 · DOI
- Reich, 2018, C. elegans ADARs antagonize silencing of cellular dsRNAs by the antiviral RNAi pathway, Genes Dev., 32, 271, 10.1101/gad.310672.117 · DOI
- van Eyk, 2019, Non-self mutation: double-stranded RNA elicits antiviral pathogenic response in a Drosophila model of expanded CAG repeat neurodegenerative diseases, Hum. Mol. Genet., 28, 3000, 10.1093/hmg/ddz096 · DOI
- Savva, 2013, RNA editing regulates transposon-mediated heterochromatic gene silencing, Nat. Commun., 4, 2745, 10.1038/ncomms3745 · DOI · Paper page
- Tsai, 2020, Epigenetic and epitranscriptomic regulation of viral replication, Nat. Rev. Microbiol., 18, 559, 10.1038/s41579-020-0382-3 · DOI · Paper page
- Miyamura, 2003, Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria, Am. J. Hum. Genet., 73, 693, 10.1086/378209 · DOI · Paper page
- Wang, 2019, Seven novel mutations of ADAR in multi-ethnic pedigrees with dyschromatosis symmetrica hereditaria in China, Mol. Genet. Genomic Med., 7, 10.1002/mgg3.905 · DOI
- Stenson, 2017, The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies, Hum. Genet., 136, 665, 10.1007/s00439-017-1779-6 · DOI · Paper page
- Zhang, 2013, The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria, Br. J. Dermatol., 169, 637, 10.1111/bjd.12401 · DOI
- Suganuma, 2020, Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria, Pigment Cell Melanoma Res., 33, 591, 10.1111/pcmr.12863 · DOI
- Gacem, 2020, ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development, Nat. Commun., 11, 198, 10.1038/s41467-019-14090-5 · DOI
- Hayashi, 2013, Dyschromatosis symmetrica hereditaria, J. Dermatol., 40, 336, 10.1111/j.1346-8138.2012.01661.x · DOI
- Crow, 2014, Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia, Neuropediatrics, 45, 386, 10.1055/s-0034-1389161 · DOI
- Livingston, 2014, A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1, J. Med. Genet., 51, 76, 10.1136/jmedgenet-2013-102038 · DOI · Paper page
- Crow, 2020, Cardiac valve involvement in ADAR-related type I interferonopathy, J. Med. Genet., 57, 475, 10.1136/jmedgenet-2019-106457 · DOI
- Schmelzer, 2018, Variable clinical phenotype in two siblings with Aicardi-Goutieres syndrome type 6 and a novel mutation in the ADAR gene, Eur. J. Paediatr. Neurol., 22, 186, 10.1016/j.ejpn.2017.11.003 · DOI
- Kondo, 2008, Dyschromatosis symmetrica hereditaria associated with neurological disorders, J. Dermatol., 35, 662, 10.1111/j.1346-8138.2008.00540.x · DOI
- Kono, 2018, Bilateral striatal necrosis and dyschromatosis symmetrica hereditaria: A-I editing efficiency of ADAR1 mutants and phenotype expression, Br. J. Dermatol., 179, 509
- Kono, 2016, Dyschromatosis symmetrica hereditaria and Aicardi-Goutieres syndrome 6 are phenotypic variants caused by ADAR1 mutations, J. Invest. Dermatol., 136, 875, 10.1016/j.jid.2015.12.034 · DOI
- Comabella, 2009, Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis, Arch. Neurol., 66, 972, 10.1001/archneurol.2009.150 · DOI
- Hornbeck, 2015, PhosphoSitePlus, 2014: mutations, PTMs and recalibrations, Nucleic Acids Res., 43, D512, 10.1093/nar/gku1267 · DOI · Paper page
- Fumagalli, 2015, Principles governing A-to-I RNA editing in the breast cancer transcriptome, Cell Rep., 13, 277, 10.1016/j.celrep.2015.09.032 · DOI · Paper page
- Paz-Yaacov, 2015, Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors, Cell Rep., 13, 267, 10.1016/j.celrep.2015.08.080 · DOI · Paper page
- Liu, 2019, Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss, Nat. Med., 25, 95, 10.1038/s41591-018-0302-5 · DOI · Paper page
- Gannon, 2018, Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells, Nat. Commun., 9, 5450, 10.1038/s41467-018-07824-4 · DOI · Paper page
- Jiang, 2020, Progress and challenges in precise treatment of tumors with PD-1/PD-L1 blockade, Front. Immunol., 11, 339, 10.3389/fimmu.2020.00339 · DOI
- Xu, 2018, ADAR1 editing and its role in cancer, Genes (Basel), 10, 12, 10.3390/genes10010012 · DOI
- Rice, 2013, Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, Lancet Neurol., 12, 1159, 10.1016/S1474-4422(13)70258-8 · DOI · Paper page
- Crow, 2015, Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1, Am. J. Med. Genet. A, 167A, 296, 10.1002/ajmg.a.36887 · DOI · Paper page
- Kono, 2019, Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: an update, J. Dermatol. Sci., 93, 75, 10.1016/j.jdermsci.2019.01.004 · DOI
- Haralambieva, 2010, 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine, Hum. Immunol., 71, 383, 10.1016/j.humimm.2010.01.004 · DOI
- Wu, 2012, Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese, Antivir. Res., 94, 272, 10.1016/j.antiviral.2012.03.004 · doi:10.1016/j.antiviral.2012.03.004
- Wu, 2014, SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission, Curr. Biol., 24, 621, 10.1016/j.cub.2014.02.026 · DOI · Paper page
- Haralambieva, 2011, Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine, Vaccine, 29, 8988, 10.1016/j.vaccine.2011.09.043 · DOI
- Kennedy, 2014, Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination, Hum. Genet., 133, 1407, 10.1007/s00439-014-1471-z · DOI
- Ovsyannikova, 2015, Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children, Immunogenetics, 67, 547, 10.1007/s00251-015-0864-z · DOI
- Medrano, 2017, ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients, Sci. Rep., 7, 12918, 10.1038/s41598-017-12885-4 · DOI
- Permuth, 2016, Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration, Oncotarget, 7, 72381, 10.18632/oncotarget.10546 · DOI
- Hwang, 2006, Genetic predisposition of responsiveness to therapy for chronic hepatitis C, Pharmacogenomics, 7, 697, 10.2217/14622416.7.5.697 · DOI
- Welzel, 2009, Variants in interferon-alpha pathway genes and response to pegylated interferon-alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial, Hepatology, 49, 1847, 10.1002/hep.22877 · DOI
- El-Derany, 2016, Integrative role of vitamin D related and interleukin-28B genes polymorphism in predicting treatment outcomes of chronic hepatitis C, BMC Gastroenterol., 16, 19, 10.1186/s12876-016-0440-5 · DOI
- Pankratz, 2010, Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment, BMC Immunol., 11, 48, 10.1186/1471-2172-11-48 · DOI
Cited by
RNA modifications: importance in immune cell biology and related diseases
Cui, L., Ma, R., Cai, J., Guo, C., Chen, Z., Yao, L., Wang, Y., Fan, R., Wang, X., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01175-9 · Cited by 405
RNA modifications in physiology and disease: towards clinical applications
Delaunay, S., Helm, M., & Frye, M. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00645-2 · Cited by 345
Biochemical profiling and structural basis of ADAR1-mediated RNA editing
Deng, X., Sun, L., Zhang, M., Basavaraj, R., Wang, J., Weng, Y.-L., & Gao, Y. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.02.017 · Cited by 19
ADBP-1 regulates ADR-2 nuclear localization to control editing substrate selection
Eliad, B., Schneider, N., Ben-Naim Zgayer, O., Amichan, Y., Glaser, F., Erdmann, E. A., Rajendren, S., Hundley, H. A., & Lamm, A. T. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae641 · Cited by 7
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Self-citation
Metadata
- Authors
- Quin, J., Sedmík, J., Vukić, D., Khan, A., Keegan, L. P., & O’Connell, M. A.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 46
- Issue
- 9
- Pages
- 758-771
- ISSN
- 0968-0004
- Cited by
- 148
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- GAČR (20-11101S)
- Ministerstvo Školství, Mládeže a Tělovýchovy (GA\u010CR 19-16963S, LTC18052)
- European Commission (867470)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ADAR RNA Modifications, the Epitranscriptome and Innate Immunity. https://app.cochat.ai/papers/10.1016/j.tibs.2021.02.002
- The paper
- Quin, J., Sedmík, J., Vukić, D., Khan, A., Keegan, L. P., & O’Connell, M. A. (2021). ADAR RNA Modifications, the Epitranscriptome and Innate Immunity. Trends in Biochemical Sciences. https://doi.org/10.1016/j.tibs.2021.02.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.